Pharma Foes Both Want Wins In Drug Access Antitrust Suit
Par Pharmaceuticals and Fresenius both want a New Jersey federal judge to hand them wins in a lawsuit accusing Par of using its monopoly on an antidiuretic drug to raise prices...To view the full article, register now.
Already a subscriber? Click here to view full article